Histological changes of gastric mucosa after Helicobacter pylori eradication: A systematic review and meta-analysis

World Journal of Gastroenterology

Volumn 20, Issue 19, 2014, Pages 5903-5911

  Kong, Yan Jun ^a   Yi, Hong Gang ^b   Dai, Jun Cheng ^b   Wei, Mu Xin ^a,c,d  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^d HiPep Laboratories   (Japan)

Author keywords

Gastric atrophy; Gastric mucosa; Helicobacter pylori eradication; Intestinal metaplasia; Meta analysis; Pathological changes

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; ANTIINFECTIVE AGENT;

ARTICLE; ATROPHY; BACTERIAL CLEARANCE; DATA EXTRACTION; GASTRIC ATROPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; QUALITY CONTROL; STOMACH MUCOSA; SYSTEMATIC REVIEW; ATROPHIC GASTRITIS; COMORBIDITY; DISEASE COURSE; ENTEROPATHY; HELICOBACTER INFECTIONS; METAPLASIA; MICROBIOLOGY; PATHOLOGY; STOMACH; STOMACH DISEASE;

ANTI-BACTERIAL AGENTS; COMORBIDITY; DISEASE PROGRESSION; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL DISEASES; METAPLASIA; STOMACH; STOMACH DISEASES;

EID: 84901199511     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i19.5903     Document Type: Article

References (57)

1. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006; 14: 21-33 [PMID: 16501831 DOI: 10.1177/106689690601400105]
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49 [PMID: 14320675]
3. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60 [PMID: 49653 DOI: 10.1016/S0140-6736(75)90498-5]
4. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8: S4-66 [PMID: 11602373]
5. Parkin DM. International variation. Oncogene 2004; 23: 6329-6340 [PMID: 15322508 DOI: 10.1038/sj.onc.1207726]
6. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition-Gastric Cancer 1998; 1: 10-24 [PMID: 11957040]
7. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
8. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24 [PMID: 9207257 DOI: 10.1016/ S0016-5085(97)70075-1]
9. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55: 1545-1552 [PMID: 16603635 DOI: 10.1136/gut.2005.080358]
10. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007; 445: 915-918 [PMID: 17287725 DOI: 10.1038/nature05562]
11. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9 Suppl 2: 33-39 [PMID: 8547526]
12. Blaser MJ. The versatility of Helicobacter pylori in the adaptation to the human stomach. J Physiol Pharmacol 1997; 48: 307-314 [PMID: 9376613]
13. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997; 25: 973-978 [PMID: 9402340 DOI: 10.1086/516067]
14. Tepes B. Can gastric cancer be prevented? J Physiol Pharmacol 2009; 60 Suppl 7: 71-77 [PMID: 20388948]
15. van der Hulst RW, van der Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, Kruizinga SP, Dankert J, Tytgat GN. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30 [PMID: 9207258 DOI: 10.1016/ S0016-5085(97)70076-3]
16. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004; 53: 12-20 [PMID: 14684569]
17. Mohammadi M, Redline R, Nedrud J, Czinn S. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996; 64: 238-245 [PMID: 8557346]
18. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353 [PMID: 11511555 DOI: 10.1136/gut.49.3.347]
19. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740 [PMID: 1458460]
20. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-1179 [PMID: 9609753 DOI: 10.1016/S0016-5085(98)70422-6]
21. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Mégraud F, Xiao SD, Sugano K, Nyrén O. Helicobacter pylori eradication has the potential to prevent gastric cancer: a stateof-the-art critique. Am J Gastroenterol 2005; 100: 2100-2115 [PMID: 16128957 DOI: 10.1111/j.1572-0241.2005.41688.x]
22. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-222 [PMID: 1912431 DOI: 10.1111/ j.14401746.1991.tb01468.x]
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 [PMID: 8827022 DOI: 10.1097/00000478-199610000-00001]
24. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2004; (1): CD004013 [PMID: 14974052 DOI: 10.1002/14651858.CD004013.pub2]
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188 [PMID: 3802833 DOI: 10.1016/0197-2456(86)90046-2]
26. Sutton AJ, Abrams KR, Jones DR. Methods for Meta-Analysis in Medical Research. New York: John Wiley and Sons, Ltd, 2000
27. Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res 2001; 10: 251-265 [PMID: 11491412 DOI: 10.1191/096228001678227776]
28. Annibale B, Aprile MR, D'ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000; 14: 625-634 [PMID: 10792127 DOI: 10.1046/j.1365-2036.2000.00752.x]
29. Wambura C, Aoyama N, Shirasaka D, Kuroda K, Maekawa S, Ebara S, Watanabe Y, Tamura T, Kasuga M. Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004; 16: 969-979 [PMID: 15371919 DOI: 10.1097 /00042737-200410000-00004]
30. Annibale B, Di Giulio E, Caruana P, Lahner E, Capurso G, Bordi C, Delle Fave G. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002; 16: 1723-1731 [PMID: 12269964 DOI: 10.1046/j.1365-2036.2002.01336.x]
31. Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective followup study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-1126 [PMID: 15854174 DOI: 10.1111/j.1365-2036.2005.02459.x]
32. Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, Mazzoni C, Paparo GF, Stanghellini V, Caletti G. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-1431 [PMID: 9732919]
33. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14 [PMID: 10889149 DOI: 10.1053/ gast.2000.8550]
34. Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 1449-1456 [PMID: 12182744 DOI: 10.1046/j.1365-2036.2002.01311.x]
35. Lahner E, Bordi C, Cattaruzza MS, Iannoni C, Milione M, Delle Fave G, Annibale B. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 22: 471-481 [PMID: 16128686 DOI: 10.1111/j.1365-2036.2005.02582.x]
36. Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol 2010; 25: 544-547 [PMID: 19817964 DOI: 10.1111/j.1440-1746.2009.05995.x]
37. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, Yokoyama T, Watanabe M. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-386 [PMID: 11242498 DOI: 10.7326/0003-4819-134-5-2001 03060-00010]
38. Iacopini F, Consolazio A, Bosco D, Marcheggiano A, Bella A, Pica R, Paoluzi OA, Crispino P, Rivera M, Mottolese M, Nardi F, Paoluzi P. Oxidative damage of the gastric mucosa in Heli-cobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter 2003; 8: 503-512 [PMID: 14535997 DOI: 10.1046/j.15235378.2003.00172.x]
39. Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, Tanaka S, Yoshihara M. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther 2003; 18: 245-252 [PMID: 12869086 DOI: 10.1046/ j.1365-2036.2003.01669.x]
40. Lu B, Chen MT, Fan YH, Liu Y, Meng LN. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J Gastroenterol 2005; 11: 6518-6520 [PMID: 16425426]
41. Ruiz B, Garay J, Correa P, Fontham ET, Bravo JC, Bravo LE, Realpe JL, Mera R. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001; 96: 3281-3287 [PMID: 11774937 DOI: 10.1111/j.1572-0241.2001.05326.x]
42. Yoshio O, Jun M, Mitsuru K, Yasuo M, Trumasa H, Yasuhiko O. Five-year follow-up study on histological and endoscopic alterations in the gastric mucosa after Helicobacter pylori eradication. Dig Endosc 2004; 16: 213-218 [DOI: 10.1111/ j.1443-1661.2004.00360.x]
43. Yamada T, Miwa H, Fujino T, Hirai S, Yokoyama T, Sato N. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol 2003; 36: 405-410 [PMID: 12702982 DOI: 10.1097/00004836-200305000-00009]
44. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16: 1923-1932 [PMID: 12390101 DOI: 10.1046/j.1365-2036.2002.01346.x]
45. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12 Suppl 2: 32-38 [PMID: 17991174 DOI: 10.1111/j.1523-5378.2007.00563.x]
46. Zhou L, Sung JJ, Lin S, Jin Z, Ding S, Huang X, Xia Z, Guo H, Liu J, Chao W. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003; 116: 11-14 [PMID: 12667379]
47. Salih BA, Abasiyanik MF, Saribasak H, Huten O, Sander E. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Dig Dis Sci 2005; 50: 1517-1522 [PMID: 16110845 DOI: 10.1007/s10620-005-2871-7]
48. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-1540 [PMID: 15985559 DOI: 10.1136/gut.2005.072009]
49. Arkkila PE, Seppälä K, Färkkilä MA, Veijola L, Sipponen P. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol 2006; 41: 782-790 [PMID: 16785190 DOI: 10.1080/00365520 500463175]
50. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-1888 [PMID: 11106679 DOI: 10.1093/jnci/92.23.1881]
51. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, Xu GW, Gail MH. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-983 [PMID: 16849680 DOI: 10.1093/jnci/djj264]
52. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-642 [PMID: 9264278]
53. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194 [PMID: 14722144 DOI: 10.1001/jama.291.2.187]
54. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397 [PMID: 18675689 DOI: 10.1016/ S0140-6736(08)61159-9]
55. Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer 2009; 12: 79-87 [PMID: 19562461 DOI: 10.1007/s10120-009-0507-x]
56. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-1249 [PMID: 15306578 DOI: 10.1136/gut.2003.034629]
57. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011; 83: 253-260 [PMID: 21282951 DOI: 10.1159/000280318]